Jian I Li Wang

US Patent:

6480976, Nov 12, 2002

Filed:

Mar 13, 2000

Appl. No.:

09/523747

Inventors:

Wenwei Pan - Ocean NJ
Jian Wang - Morganville NJ

Assignee:

GlobespanVirata, Inc. - Red Bank NJ

International Classification:

G06F 1100

US Classification:

714701, 714784

Abstract:

A resource optimized interleaving/deinterleaving system comprising a Reed-Solomon encoder, a Reed-Solomon decoder, a state machine, and a memory is disclosed. Reed-Solomon encoded fastpath data is stored in memory. A stream of interleaved data with predefined parameters S, the number of DMT symbols per each Reed-Solomon codeword, D, the interleaving depth, and N, the block length is written into system memory at an adaptable rate determined by the Reed-Solomon encoder. The previously stored Reed-Solomon encoded fastpath data is automatically reassembled and buffered with the interleaved data to form appropriate DMT transmission symbols. The DMT transmission symbols are then read out of the system memory at a rate determined by the next processing function, i. e. , tone ordering. A method of using one Reed-Solomon encoder/decoder with the integrated interleaving/deinterleaving system to support dual single latency DMT systems is also disclosed.

US Patent:

6536001, Mar 18, 2003

Filed:

Mar 13, 2000

Appl. No.:

09/524464

Inventors:

Lujing Cai - Tinton Falls NJ
Wenwei Pan - Ocean NJ
Jian Wang - Morganville NJ

Assignee:

Globespanvirata, Inc. - Red Bank NJ

International Classification:

H03M 1327

US Classification:

714701

Abstract:

A circuit and method that provides a one-step real time pointer for interleaving/deinterleaving that uses a single modulo operation is disclosed. The single modulo pointer of the present invention may be used to increase data throughput through a data interleaver/deinterleaver. A memory address pointer consistent with the present invention may be implemented with a multiplexer, an adder, a counter, and a modulo operator. A method for convolutional interleaving/deinterleaving is also disclosed.

US Patent:

6642227, Nov 4, 2003

Filed:

Apr 10, 2002

Appl. No.:

10/121035

Inventors:

Jingrong Cao - Newton MA
Jeremy Green - Burlington MA
Young-Choon Moon - Lexington MA
Jian Wang - Boston MA
Mark Ledeboer - Acton MA
Edmund Harrington - South Boston MA
Huai Gao - Natick MA

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

C07D40904

US Classification:

5142278, 5142358, 51425219, 514275, 544 60, 544122, 544331

Abstract:

The present invention provides compounds of formula I: or a pharmaceutically acceptable derivative o thereof, wherein A, B, R , R , R , R , and R are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of JNK, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli; Lck and Src kinase. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.

US Patent:

6689778, Feb 10, 2004

Filed:

Jun 14, 2002

Appl. No.:

10/171895

Inventors:

Guy Bemis - Arlington MA
Huai Gao - Natick MA
Edmund Harrington - South Boston MA
Francesco Salituro - Marlboro MA
Jian Wang - Boston MA
Mark Ledeboer - Acton MA

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

C07D41304

US Classification:

5142358, 51425219, 514275, 544122, 544331

Abstract:

The present invention provides compounds of formula I: or a pharmaceutically acceptable derivative thereof, wherein AâB is NâO or OâN and G, R , R , R , and R are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of Src and Lck kinase. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.

US Patent:

6762179, Jul 13, 2004

Filed:

May 23, 2002

Appl. No.:

10/154118

Inventors:

John Cochran - Marshfield MA
Suganthini Nanthakumar - Newton MA
Edmund Harrington - South Boston MA
Jian Wang - Boston MA

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

A61K 31505

US Classification:

5142278, 544330, 544331, 544332, 544122, 544 60, 5142315, 51425214, 514275

Abstract:

The present invention provides a compound of formula I: or a pharmaceutically acceptable derivative thereof, wherein Ar is phenyl and R is as defined in the specification. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3, Aurora2, and Syk mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

US Patent:

6859303, Feb 22, 2005

Filed:

Jun 17, 2003

Appl. No.:

10/463883

Inventors:

Jian Wang - Orefield PA, US
Hubert Kostal - Fair Haven NJ, US

Assignee:

NanoOpto Corporation - Somerset NJ

International Classification:

G02F001/00
G02B006/26
H01L021/44

US Classification:

359321, 359322, 385 27, 438615

Abstract:

The present invention is directed to a method for enhancing functionality for photonic devices each including at least one operable surface. This method includes stacking the photonic devices such that each of the operable surfaces are aligned to form a composite surface, applying a film adapted to receive a replication to the composite surface and replicating a pattern of nanostructures in the applied film. Substantially, each of the operable surfaces is replicated with a sufficient portion of the replicated pattern of nanostructures to enhance operation of the devices by performing a given function associated with the nanostructures.

US Patent:

6920272, Jul 19, 2005

Filed:

Jun 17, 2003

Appl. No.:

10/463473

Inventors:

Jian Wang - Orefield PA, US

Assignee:

NanoOpto Corporation - Somerset NJ

International Classification:

G02B006/10

US Classification:

385129, 359332

Abstract:

A wavelength tunable device for operating on at least a portion of energy propagating through a waveguide is disclosed. The wavelength tunable device includes an upper cladding and a lower cladding having a core substantially disposed there between and suitable for optically coupling to the waveguide, a pattern of nanostructures positioned substantially on the upper cladding distal to the core so as to define a reflectivity for energy propagating through the waveguide, and, a movable membrane aligned with the pattern of nanostructures so as to at least partially define a gap there between. This gap may be selectively controlled upon actuation of the movable membrane so as to cause a corresponding change in the reflectivity.

US Patent:

6971057, Nov 29, 2005

Filed:

Feb 26, 2001

Appl. No.:

09/793172

Inventors:

Marc Delvaux - Eatontown NJ, US
Wenwei Pan - Highlands NJ, US
Jian Wang - Morganville NJ, US

Assignee:

GlobespanVirata, Inc. - Red Bank NJ

International Classification:

H03M013/03

US Classification:

714788, 714702, 714762

Abstract:

A memory optimized system and method for data interleaving/de-interleaving are disclosed. A data interleaver/de-interleaver may be implemented with a memory device and an improved data interleaver/de-interleaver. The improved data interleaver/de-interleaver may be implemented with a controller, a first array, and a second array. The first array identifies a maximum depth value for each of a plurality of memory segments responsive to both a block data length and the desired interleaving/de-interleaving depth. The second array comprises an index associated with each of the plurality of memory segments that may be used to derive write and read addresses. In its broadest terms, the method can be described as: identifying a block data length, N, and an interleaver/de-interleaver depth, D; initializing a set of pointers associated with each of N memory segments; initializing a set of pointer maximum values responsive to the relative magnitude of N and D, identifying a memory index responsive to a base address and the set of pointer maximum values; using a memory segment identifier, a word identifier, and a byte identifier along with the memory index and the pointers to write/read the bytes of code words.